CytomX Therapeutics, Inc.

NASDAQ:CTMX

Biotechnology

Healthcare
$1.88 -0.91%

-$0.03 today

Market cap
$409.85M
Beta
2.09
P/E (TTM)
-8.8
EPS (TTM)
-$0.33
52W Low $1.72High $8.21

Volume 4.39M

Average 4.99M

Balance Sheet

Inspect the capital base behind the business.

Assets

$151.57M

FY 2025 · Annual

+25.7% YoY

Liabilities

$52.56M

FY 2025 · Annual

-56.6% YoY

Equity

$99.01M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents205.53M193.65M17.17M38.05M12.67M
Short-term Investments99.7M0157.34M62.57M124.39M
Net Receivables790K35.99M3.43M3.1M2.01M
Inventory00000
Other Current Assets07.47M5M3.58M4.86M
Total Current Assets310.3M237.1M182.94M107.31M143.92M
Property, Plant & Equipment (Net)25.32M21.02M16.18M10.6M4.7M
Goodwill949K949K949K949K949K
Intangible Assets1.02M875K729K583K438K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.82M944K1M1.09M1.56M
Total Non-current Assets29.11M23.79M18.86M13.23M7.65M
Total Assets339.41M260.89M201.79M120.53M151.57M
Account Payables2.82M2.81M1.46M1.09M1.3M
Short-term Debt00004.24M
Tax Payables00000
Deferred Revenue40.82M121.27M132.27M67.2M26.88M
Other Current Liabilities009.44M05.99M
Total Current Liabilities77.87M152.61M155.91M85.77M46.62M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)243.94M180.06M80.05M26.86M1.59M
Other Non-current Liabilities003.89M4.12M4.35M
Total Non-current Liabilities262M194.03M93.33M35.22M5.94M
Total Liabilities339.87M346.64M249.24M120.99M52.56M
Common Stock1K1K1K1K2K
Retained Earnings(623.56M)(722.88M)(723.45M)(691.58M)(711.95M)
Accumulated OCI(242K)10K95K27K111K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(459K)(85.75M)(47.45M)(456K)99.01M
Total Debt21.67M18.06M13.97M9.39M4.24M
Net Debt(183.86M)(175.59M)(3.2M)(28.67M)(8.43M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$28.8M
Short-term Investments$317.9M
Receivables$646.0K
Other Current$5.7M
Total Current Assets$353.1M
PP&E (Net)$3.4M
Goodwill$949.0K
Intangible Assets$401.0K
Other Non-current$1.6M
Total Non-current Assets$6.3M
Total Assets$359.4M

Analysis

Selected assets total $359.4M for Latest. The largest visible component is Short-term Investments at $317.9M, about 88.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 28, 2026
4/A4/A filingOct 16, 2026

How much cash does CTMX have?

CytomX Therapeutics, Inc. (CTMX) reported $12.67M in cash and equivalents in fiscal 2025.

How much debt does CTMX carry?

CytomX Therapeutics, Inc. (CTMX) reported $4.24M of total debt, with net debt of -$8.43M.